Novartis Investigative Site

Tachikawa, Tokyo 1900023

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Chronic Inducible Urticaria

Studies at this site

• A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines — Running, not enrolling
• Dose Finding Study for QAW039 in Asthma — Completed